You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Devices & Consumables

Global Nasal Vaccines Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

The global Nasal Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Nasal Vaccines production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Nasal Vaccines by regions (countries) and by Application.
The global Nasal Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Nasal Vaccines market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Nasal Vaccines markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Nasal Vaccines market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
The report includes comprehensive company profiling of leading and emerging companies competing in the global Nasal Vaccines market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Nasal Vaccines market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Nasal Vaccines market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Nasal Vaccines market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Nasal Vaccines market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Nasal Vaccines market by each application segment for the same period.
This report includes the following manufacturers:
Serum Institute of India
Bharat Biotech
Antares Pharma
INJEX Pharma GmbH
PharmaJet and Crossject
Market Segment by Type
Flu Vaccines
COVID-19 Vaccines
Other Vaccines
Market Segment by Application
Research Methodology
To compile the detailed study of the global Nasal Vaccines market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Nasal Vaccines market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Nasal Vaccines market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.

1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Nasal Vaccines Market Size Growth Rate by Type
1.2.2 Flu Vaccines
1.2.3 COVID-19 Vaccines
1.2.4 Other Vaccines
1.3 Market Segment by Application
1.3.1 Global Nasal Vaccines Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Adult
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered

2 Market Perspective
2.1 Global Nasal Vaccines Market Size (2016-2027)
2.1.1 Global Nasal Vaccines Revenue (2016-2027)
2.1.2 Global Nasal Vaccines Sales (2016-2027)
2.2 Global Nasal Vaccines Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Nasal Vaccines Sales by Regions (2016-2021)
2.2.2 Global Nasal Vaccines Revenue by Regions (2016-2021)
2.3 Global Nasal Vaccines Market Size Forecast by Region
2.3.1 Global Nasal Vaccines Sales Forecast by Region (2022-2027)
2.3.2 Global Nasal Vaccines Revenue Forecast by Region (2022-2027)
2.4 Global Top Nasal Vaccines Regions (Countries) Ranking by Market Size
2.5 Nasal Vaccines Industry Trends
2.5.1 Nasal Vaccines Market Trends
2.5.2 Nasal Vaccines Market Drivers
2.5.3 Nasal Vaccines Market Challenges
2.5.4 Nasal Vaccines Market Restraints

3 Competitive Landscape by Manufacturers
3.1 Global Top Nasal Vaccines Manufacturers by Sales (2016-2021)
3.1.1 Global Nasal Vaccines Sales by Manufacturers (2016-2021)
3.1.2 Global Nasal Vaccines Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Nasal Vaccines Sales in 2020
3.2 Global Top Manufacturers Nasal Vaccines by Revenue
3.2.1 Global Nasal Vaccines Revenue by Manufacturers (2016-2021)
3.2.2 Top Nasal Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Nasal Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Nasal Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nasal Vaccines as of 2020)
3.4 Global Nasal Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Nasal Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Nasal Vaccines Market
3.7 Key Manufacturers Nasal Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Global Nasal Vaccines Market Size by Type
4.1 Global Nasal Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Nasal Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Nasal Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Nasal Vaccines Price by Type (2016-2021)
4.2 Global Nasal Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Nasal Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Nasal Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Nasal Vaccines Price Forecast by Type (2022-2027)

5 Global Nasal Vaccines Market Size by Application
5.1 Global Nasal Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Nasal Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Nasal Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Nasal Vaccines Price by Application (2016-2021)
5.2 Global Nasal Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Nasal Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Nasal Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Nasal Vaccines Price Forecast by Application (2022-2027)

6 North America
6.1 North America Nasal Vaccines Sales Breakdown by Company
6.1.1 North America Nasal Vaccines Sales by Company (2016-2027)
6.1.2 North America Nasal Vaccines Revenue by Company (2016-2027)
6.2 North America Nasal Vaccines Market Size by Type (2016-2027)
6.2.1 North America Nasal Vaccines Sales by Type (2016-2027)
6.2.2 North America Nasal Vaccines Revenue by Type (2016-2027)
6.3 North America Nasal Vaccines Market Size by Application (2016-2027)
6.3.1 North America Nasal Vaccines Sales by Application (2016-2027)
6.3.2 North America Nasal Vaccines Revenue by Application (2016-2027)
6.4 North America Nasal Vaccines Market Size by Country
6.4.1 North America Nasal Vaccines Sales by Country (2016-2027)
6.4.2 North America Nasal Vaccines Revenue by Country (2016-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Nasal Vaccines Sales Breakdown by Company
7.1.1 Europe Nasal Vaccines Sales by Company (2016-2027)
7.1.2 Europe Nasal Vaccines Revenue by Company (2016-2027)
7.2 Europe Nasal Vaccines Market Size by Type (2016-2027)
7.2.1 Europe Nasal Vaccines Sales by Type (2016-2027)
7.2.2 Europe Nasal Vaccines Revenue by Type (2016-2027)
7.3 Europe Nasal Vaccines Market Size by Application (2016-2027)
7.3.1 Europe Nasal Vaccines Sales by Application (2016-2027)
7.3.2 Europe Nasal Vaccines Revenue by Application (2016-2027)
7.4 Europe Nasal Vaccines Market Size by Country
7.4.1 Europe Nasal Vaccines Sales by Country (2016-2027)
7.4.2 Europe Nasal Vaccines Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Nasal Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific Nasal Vaccines Sales by Company (2016-2027)
8.1.2 Asia Pacific Nasal Vaccines Revenue by Company (2016-2027)
8.2 Asia Pacific Nasal Vaccines Market Size by Type (2016-2027)
8.2.1 Asia Pacific Nasal Vaccines Sales by Type (2016-2027)
8.2.2 Asia Pacific Nasal Vaccines Revenue by Type (2016-2027)
8.3 Asia Pacific Nasal Vaccines Market Size by Application (2016-2027)
8.3.1 Asia Pacific Nasal Vaccines Sales by Application (2016-2027)
8.3.2 Asia Pacific Nasal Vaccines Revenue by Application (2016-2027)
8.4 Asia Pacific Nasal Vaccines Market Size by Regions
8.4.1 Asia Pacific Nasal Vaccines Sales by Regions
8.4.2 Asia Pacific Nasal Vaccines Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia

9 Latin America
9.1 Latin America Nasal Vaccines Sales Breakdown by Company
9.1.1 Latin America Nasal Vaccines Sales by Company (2016-2027)
9.1.2 Latin America Nasal Vaccines Revenue by Company (2016-2027)
9.2 Latin America Nasal Vaccines Market Size by Type (2016-2027)
9.2.1 Latin America Nasal Vaccines Sales by Type (2016-2027)
9.2.2 Latin America Nasal Vaccines Revenue by Type (2016-2027)
9.3 Latin America Nasal Vaccines Market Size by Application (2016-2027)
9.3.1 Latin America Nasal Vaccines Sales by Application (2016-2027)
9.3.2 Latin America Nasal Vaccines Revenue by Application (2016-2027)
9.4 Latin America Nasal Vaccines Market Size by Country
9.4.1 Latin America Nasal Vaccines Sales by Country (2016-2027)
9.4.2 Latin America Nasal Vaccines Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
9.4.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Nasal Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa Nasal Vaccines Sales by Company (2016-2027)
10.1.2 Middle East and Africa Nasal Vaccines Revenue by Company (2016-2027)
10.2 Middle East and Africa Nasal Vaccines Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Nasal Vaccines Sales by Type (2016-2027)
10.2.2 Middle East and Africa Nasal Vaccines Revenue by Type (2016-2027)
10.3 Middle East and Africa Nasal Vaccines Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Nasal Vaccines Sales by Application (2016-2027)
10.3.2 Middle East and Africa Nasal Vaccines Revenue by Application (2016-2027)
10.4 Middle East and Africa Nasal Vaccines Market Size by Country
10.4.1 Middle East and Africa Nasal Vaccines Sales by Country (2016-2027)
10.4.2 Middle East and Africa Nasal Vaccines Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Sanofi Nasal Vaccines Products and Services
11.1.5 Sanofi Nasal Vaccines SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 AstraZeneca Nasal Vaccines Products and Services
11.2.5 AstraZeneca Nasal Vaccines SWOT Analysis
11.2.6 AstraZeneca Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Abbott Nasal Vaccines Products and Services
11.3.5 Abbott Nasal Vaccines SWOT Analysis
11.3.6 Abbott Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 GlaxoSmithKline Nasal Vaccines Products and Services
11.4.5 GlaxoSmithKline Nasal Vaccines SWOT Analysis
11.4.6 GlaxoSmithKline Recent Developments
11.5 Serum Institute of India
11.5.1 Serum Institute of India Corporation Information
11.5.2 Serum Institute of India Overview
11.5.3 Serum Institute of India Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Serum Institute of India Nasal Vaccines Products and Services
11.5.5 Serum Institute of India Nasal Vaccines SWOT Analysis
11.5.6 Serum Institute of India Recent Developments
11.6 Bharat Biotech
11.6.1 Bharat Biotech Corporation Information
11.6.2 Bharat Biotech Overview
11.6.3 Bharat Biotech Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Bharat Biotech Nasal Vaccines Products and Services
11.6.5 Bharat Biotech Nasal Vaccines SWOT Analysis
11.6.6 Bharat Biotech Recent Developments
11.7 Antares Pharma
11.7.1 Antares Pharma Corporation Information
11.7.2 Antares Pharma Overview
11.7.3 Antares Pharma Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Antares Pharma Nasal Vaccines Products and Services
11.7.5 Antares Pharma Nasal Vaccines SWOT Analysis
11.7.6 Antares Pharma Recent Developments
11.8 INJEX Pharma GmbH
11.8.1 INJEX Pharma GmbH Corporation Information
11.8.2 INJEX Pharma GmbH Overview
11.8.3 INJEX Pharma GmbH Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 INJEX Pharma GmbH Nasal Vaccines Products and Services
11.8.5 INJEX Pharma GmbH Nasal Vaccines SWOT Analysis
11.8.6 INJEX Pharma GmbH Recent Developments
11.9 BioDiem
11.9.1 BioDiem Corporation Information
11.9.2 BioDiem Overview
11.9.3 BioDiem Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 BioDiem Nasal Vaccines Products and Services
11.9.5 BioDiem Nasal Vaccines SWOT Analysis
11.9.6 BioDiem Recent Developments
11.10 PharmaJet and Crossject
11.10.1 PharmaJet and Crossject Corporation Information
11.10.2 PharmaJet and Crossject Overview
11.10.3 PharmaJet and Crossject Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 PharmaJet and Crossject Nasal Vaccines Products and Services
11.10.5 PharmaJet and Crossject Nasal Vaccines SWOT Analysis
11.10.6 PharmaJet and Crossject Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Nasal Vaccines Value Chain Analysis
12.2 Nasal Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nasal Vaccines Production Mode & Process
12.4 Nasal Vaccines Sales and Marketing
12.4.1 Nasal Vaccines Sales Channels
12.4.2 Nasal Vaccines Distributors
12.5 Nasal Vaccines Customers
13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 130